135 related articles for article (PubMed ID: 10901167)
21. Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl
Elmahdy NA; Sokar SS; Salem ML; Sarhan NI; Abou-Elela SH
Biomed Pharmacother; 2017 May; 89():1378-1386. PubMed ID: 28320105
[TBL] [Abstract][Full Text] [Related]
22. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.
Nevzorova YA; Hu W; Cubero FJ; Haas U; Freimuth J; Tacke F; Trautwein C; Liedtke C
Biochim Biophys Acta; 2013 Oct; 1832(10):1765-75. PubMed ID: 23770341
[TBL] [Abstract][Full Text] [Related]
24. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
25. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition.
Sun YL; Bai T; Zhou L; Zhu RT; Wang WJ; Liang RP; Li J; Zhang CX; Gou JJ
J Cell Physiol; 2021 Jun; 236(6):4313-4329. PubMed ID: 33230845
[TBL] [Abstract][Full Text] [Related]
26. Amelioration of CCl
Hamid M; Liu D; Abdulrahim Y; Liu Y; Qian G; Khan A; Gan F; Huang K
Res Vet Sci; 2017 Oct; 114():202-211. PubMed ID: 28482267
[TBL] [Abstract][Full Text] [Related]
27. Alteration of AP-endonuclease1 expression in curcumin-treated fibrotic rats.
Bassiouny AR; Zaky A; Kandeel KM
Ann Hepatol; 2011; 10(4):516-30. PubMed ID: 21911894
[TBL] [Abstract][Full Text] [Related]
28. The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis.
Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Calatroni A
Chem Biol Interact; 2004 Jul; 148(3):125-38. PubMed ID: 15276869
[TBL] [Abstract][Full Text] [Related]
29. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
[TBL] [Abstract][Full Text] [Related]
30. Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms.
Cubero FJ; Nieto N
Hepatology; 2008 Dec; 48(6):2027-2039. PubMed ID: 19003881
[TBL] [Abstract][Full Text] [Related]
31. Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha.
Urtasun R; Cubero FJ; Vera M; Nieto N
Gastroenterology; 2009 Apr; 136(4):1410-22, e1-4. PubMed ID: 19250650
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats.
Yao XX; Jiang SL; Tang YW; Yao DM; Yao X
World J Gastroenterol; 2005 May; 11(17):2583-90. PubMed ID: 15849816
[TBL] [Abstract][Full Text] [Related]
33. Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells.
Lu G; Shimizu I; Cui X; Itonaga M; Tamaki K; Fukuno H; Inoue H; Honda H; Ito S
J Med Invest; 2002 Aug; 49(3-4):172-81. PubMed ID: 12323007
[TBL] [Abstract][Full Text] [Related]
34. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
35. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
[TBL] [Abstract][Full Text] [Related]
36. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
37. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl₄-treated rats.
Clichici S; Olteanu D; Nagy AL; Oros A; Filip A; Mircea PA
J Med Food; 2015 Mar; 18(3):290-8. PubMed ID: 25133972
[TBL] [Abstract][Full Text] [Related]
38. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
39. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of Mentha piperita L. leaf essential oil against CCl
Bellassoued K; Ben Hsouna A; Athmouni K; van Pelt J; Makni Ayadi F; Rebai T; Elfeki A
Lipids Health Dis; 2018 Jan; 17(1):9. PubMed ID: 29316974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]